Dr. Daniel Trifiletti, MD

Dr. Trifiletti practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Trifiletti's NPI, 1326308073, was assigned on May 29, 2012. Dr. Trifiletti graduated from University Of Florida College Of Medicine in 2012. Dr. Trifiletti holds Florida license ME131093.

Dr. Trifiletti's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Trifiletti's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trifiletti practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Trifiletti's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Trifiletti is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Trifiletti's licenses on file in 3 states: Florida, Virginia and Pennsylvania.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation and lung cancer radiation among the conditions Dr. Trifiletti treats.

CMS data shows 2,239 Medicare services from Dr. Trifiletti across 17 procedure codes in 2024, for 348 Medicare patients. Medicare paid $139,545 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 348 Medicare patients who saw Dr. Trifiletti in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trifiletti's median patient age at 67, with 63% women.

In 2024, Dr. Trifiletti wrote 44 Medicare Part D claims for 34 patients. 98% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $101 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Trifiletti for performance year 2024, reported as part of a group. Dr. Trifiletti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trifiletti as offering telehealth.

Dmand AI links 264 papers to Dr. Trifiletti, published from 2012 to 2025. 2020 was the busiest year, with 34. The most frequent topics are Radiosurgery, Brain Neoplasms and Glioblastoma. Dr. Trifiletti has published most often in J Neurooncol. Dr. Trifiletti's most frequent co-authors are Jason P. Sheehan, Eric J. Lehrer, MD and Jennifer L. Peterson, MD.

Dmand AI links Dr. Trifiletti to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Brain Neoplasms, Central Nervous System Neoplasms and Glioma. Mayo Clinic sponsors the most, 3.

CMS Open Payments shows 33 general payments to Dr. Trifiletti from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 87% of the total. Boston Scientific Corporation paid the most, $11,355.

Dr. Trifiletti graduated from University Of Florida College Of Medicine in 2012.

Dr. Trifiletti is in network with 7 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.